导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.34% | 626/1050 |
| 近一周 | -1.31% | 177/1104 |
| 近一月 | -0.11% | 91/1102 |
| 近一季 | -0.39% | 267/1092 |
| 近半年 | -4.12% | 569/1070 |
| 近一年 | -0.97% | 605/1018 |
| 近两年 | 45.07% | 538/926 |
| 近三年 | 34.18% | 359/834 |
| 成立以来 | 80.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.25% 663/1070 |
-6.29% 826/1101 |
- - |
- - |
| 2025 | 21.24% 646/1065 |
5.66% 363/1014 |
3.68% 378/1038 |
6.48% 909/1050 |
3.93% 191/1065 |
| 2024 | 22.93% 68/1011 |
5.71% 95/960 |
4.91% 98/983 |
11.65% 487/991 |
-0.71% 363/1011 |
| 2023 | 2.44% 70/952 |
10.11% 115/880 |
1.05% 132/895 |
-1.39% 130/915 |
-6.64% 645/952 |
| 2022 | -9.12% 78/867 |
-9.15% 88/773 |
2.33% 656/806 |
-10.17% 245/845 |
8.83% 102/867 |
| 2021 | 12.28% 215/740 |
3.52% 70/580 |
5.12% 465/659 |
-3.32% 298/704 |
6.73% 156/740 |
| 2020 | 13.48% 395/554 |
-10.76% 387/419 |
13.91% 367/466 |
6.38% 335/517 |
4.94% 441/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 鹏华优选价值股票A VS. 东吴新产业精选股票A(580008) |